Paydirt
DR
Insider

David P. Rosenbaum

Chief Development Officer

David P. Rosenbaum (Chief Development Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Ardelyx, Inc. (ARDX). The largest single filing was $343K of ARDX (49,564 sh × $6.92, as filed), executed Sep 27 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$670K
shares × price, as filed
Last traded
Nov 6 2024
Filed Nov 8 2024

Median ADV $16.1M across their filed names

Open performance→
Volume by month
$343K$171K$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $343KNov 2024 · sells $327K
Buys $0 Sells $670K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 24 months

Most traded names
ARDX Ardelyx, Inc. ARDX · 0 buys · 3 sells 3 filings
Recent filings
ARDXSALE Ardelyx, Inc. View filing → $166K
27,171 sh × $6.10
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET ARDXSALE Ardelyx, Inc. View filing → $162K
27,172 sh × $5.95
Exec Nov 4 2024
Filed Nov 6 2024 · 5:30 PM ET ARDXSALE Ardelyx, Inc. View filing → $343K
49,564 sh × $6.92
Exec Sep 27 2024
Filed Oct 1 2024 · 5:30 PM ET